| Patrick Theodore Gomella, MD, MPH | |
|
1245 Highland Ave Ste 302, Abington, PA 19001-3724 | |
| (215) 481-7700 | |
| Not Available |
| Full Name | Patrick Theodore Gomella |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 15 Years |
| Location | 1245 Highland Ave Ste 302, Abington, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093058315 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD473709 (Pennsylvania) | Primary |
| 208800000X | Urology | D0085017 (Maryland) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thomas Jefferson University Hospital | Philadelphia, PA | Hospital |
| Abington Memorial Hospital | Abington, PA | Hospital |
| Abington Health Lansdale Hospital | Lansdale, PA | Hospital |
| Albert Einstein Medical Center | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abington Memorial Hospital | 3274437736 | 528 |
| Einstein Practice Plan Inc | 2769395896 | 591 |
News Archive
Doximity, the leading online medical network with over half of all US doctors as members, and the Society of Hospital Medicine, the medical society representing the fastest growing specialty in healthcare, announced today a partnership to better serve the population of US hospitalists. By combining their clinical and digital strengths, SHM and Doximity will provide hospitalists better tools to collaborate and care for their patients.
Nuclear medicine is the branch of medicine that uses radioactive materials to provide diagnostics and treatments for cancer. Often, standard protocols involve using radioactive isotopes developed to image as well as weaken cancer cells in the body. With more than 30 years of research in radiopharmaceutical chemistry, Silvia Jurisson, a researcher at the University of Missouri, is a world-renowned scientist who continues to develop breakthrough materials used in the detection and treatment of cancer.
"During the past 24 hours, cholera has claimed the lives of nearly 200 women and children in famine-stricken Somalia," a Press TV correspondent in Mogadishu reported on Sunday. "More than 800 children suffering from the disease in refugee camps were reportedly transported to medical centers in south Mogadishu," the news service writes, adding, "As the number of sick is on the rise, doctors are facing a shortage of medicine."
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
› Verified 5 days ago
| Entity Name | Einstein Practice Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760434468 PECOS PAC ID: 2769395896 Enrollment ID: O20040219000728 |
News Archive
Doximity, the leading online medical network with over half of all US doctors as members, and the Society of Hospital Medicine, the medical society representing the fastest growing specialty in healthcare, announced today a partnership to better serve the population of US hospitalists. By combining their clinical and digital strengths, SHM and Doximity will provide hospitalists better tools to collaborate and care for their patients.
Nuclear medicine is the branch of medicine that uses radioactive materials to provide diagnostics and treatments for cancer. Often, standard protocols involve using radioactive isotopes developed to image as well as weaken cancer cells in the body. With more than 30 years of research in radiopharmaceutical chemistry, Silvia Jurisson, a researcher at the University of Missouri, is a world-renowned scientist who continues to develop breakthrough materials used in the detection and treatment of cancer.
"During the past 24 hours, cholera has claimed the lives of nearly 200 women and children in famine-stricken Somalia," a Press TV correspondent in Mogadishu reported on Sunday. "More than 800 children suffering from the disease in refugee camps were reportedly transported to medical centers in south Mogadishu," the news service writes, adding, "As the number of sick is on the rise, doctors are facing a shortage of medicine."
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
› Verified 5 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1922334697 PECOS PAC ID: 3274437736 Enrollment ID: O20100106000435 |
News Archive
Doximity, the leading online medical network with over half of all US doctors as members, and the Society of Hospital Medicine, the medical society representing the fastest growing specialty in healthcare, announced today a partnership to better serve the population of US hospitalists. By combining their clinical and digital strengths, SHM and Doximity will provide hospitalists better tools to collaborate and care for their patients.
Nuclear medicine is the branch of medicine that uses radioactive materials to provide diagnostics and treatments for cancer. Often, standard protocols involve using radioactive isotopes developed to image as well as weaken cancer cells in the body. With more than 30 years of research in radiopharmaceutical chemistry, Silvia Jurisson, a researcher at the University of Missouri, is a world-renowned scientist who continues to develop breakthrough materials used in the detection and treatment of cancer.
"During the past 24 hours, cholera has claimed the lives of nearly 200 women and children in famine-stricken Somalia," a Press TV correspondent in Mogadishu reported on Sunday. "More than 800 children suffering from the disease in refugee camps were reportedly transported to medical centers in south Mogadishu," the news service writes, adding, "As the number of sick is on the rise, doctors are facing a shortage of medicine."
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patrick Theodore Gomella, MD, MPH 1245 Highland Ave Ste 302, Abington, PA 19001-3724 Ph: (215) 481-7700 | Patrick Theodore Gomella, MD, MPH 1245 Highland Ave Ste 302, Abington, PA 19001-3724 Ph: (215) 481-7700 |
News Archive
Doximity, the leading online medical network with over half of all US doctors as members, and the Society of Hospital Medicine, the medical society representing the fastest growing specialty in healthcare, announced today a partnership to better serve the population of US hospitalists. By combining their clinical and digital strengths, SHM and Doximity will provide hospitalists better tools to collaborate and care for their patients.
Nuclear medicine is the branch of medicine that uses radioactive materials to provide diagnostics and treatments for cancer. Often, standard protocols involve using radioactive isotopes developed to image as well as weaken cancer cells in the body. With more than 30 years of research in radiopharmaceutical chemistry, Silvia Jurisson, a researcher at the University of Missouri, is a world-renowned scientist who continues to develop breakthrough materials used in the detection and treatment of cancer.
"During the past 24 hours, cholera has claimed the lives of nearly 200 women and children in famine-stricken Somalia," a Press TV correspondent in Mogadishu reported on Sunday. "More than 800 children suffering from the disease in refugee camps were reportedly transported to medical centers in south Mogadishu," the news service writes, adding, "As the number of sick is on the rise, doctors are facing a shortage of medicine."
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ:APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Deferoxamine Mesylate for Injection, USP, in two dosage strengths. Deferoxamine Mesylate is therapeutically equivalent to the reference-listed drug Desferal®, which is marketed by the innovator Novartis.
› Verified 5 days ago
A. Samaha, Urology Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Suite 210, Abington, PA 19001 Phone: 215-517-1100 | |
Ronald S Rosenthal, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1235 Old York Rd, Suite 210, Abington, PA 19001 Phone: 215-517-1100 Fax: 215-517-1130 | |
Robert S Charles, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Suite 210, Abington, PA 19001 Phone: 215-517-1100 Fax: 215-517-1130 | |
Dr. Lee Richard Schachter, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1235 Old York Rd, Suite 210, Abington, PA 19001 Phone: 215-517-1100 Fax: 215-517-1130 |